Investor profile
Charles Dunn
Private equity, Venture capital & Principal at SV Health Investors' Dementia Discovery Fund (DDF)
Charles Dunn is a Principal at SV Health Investors' Dementia Discovery Fund (DDF), whose known portfolio counts 11 companies.
Is Charles Dunn a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechDementia therapeuticsDiagnosticsDrug DiscoveryHealthcare OperationsMedTechMedical DevicesPharma
Contacts
Affiliated funds' portfolios
Principal at SV Health Investors' Dementia Discovery Fund (DDF), whose known portfolio counts 11 companies
- Artios Pharma
- TRex Bio
- Therini Bio
- Imbria Pharmaceuticals
- Mestag Therapeutics
- Enara Bio
- PayMedix
- Alchemab Therapeutics
- Draig Therapeutics
- Dualitas Therapeutics
- Adimab
Investor Profile
Charles Dunn is listed against sector Healthcare, and focus areas Biotech, Dementia therapeutics, Diagnostics and Drug Discovery in the database.
SV Health Investors' Dementia Discovery Fund (DDF) appears in Growth, Late-Stage and Seed rounds across its known deals.
What the affiliated firm has backed is the closest available signal on whether Charles Dunn is worth approaching.
Colleagues at SV Health Investors' Dementia Discovery Fund (DDF)
Dirk Landgraf
Principal
Boston, United States
Jamil M. Beg
Partner
Cambridge, United States
Brent Faduski
CFO and Partner
United States
A.J. Rossi
Investor
Boston, United States
Kate Bingham
Managing Partner
London, United Kingdom
Tom Flynn
Managing Partner
Boston, United States
Michael Balmuth
Managing Partner
Boston, United States
Paul LaViolette
Managing Partner & Chief Operating Officer
Boston, United States
Jonathan Behr
Partner
Cambridge, United States
Bruce Peacock
Vnture Partner
Berwyn, United States
Nikola Trbovic
Managing Partner
New York City, United States
James Costine
Director
London, United Kingdom
James Garvey
Managing Partner
Boston, United States
Gregory Madden
Managing Partner
Boston, United States
Georgina Ewels
Investor
London, United Kingdom
Eugene Hill
Managing Partner
Boston, United States
Mike Ross
Senior Partner
San Mateo, United States
Frequently asked questions
Who is Charles Dunn?
Charles Dunn is a private equity investor and venture capital investor based in United Kingdom, listed as Principal at SV Health Investors' Dementia Discovery Fund (DDF). The known portfolio of that firm counts 11 companies. That portfolio belongs to the firm, not to Charles Dunn personally.
What does Charles Dunn invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Dementia therapeutics, Diagnostics and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Charles Dunn invest at?
SV Health Investors' Dementia Discovery Fund (DDF) appears in Growth, Late-Stage and Seed rounds across its known deals, and Charles Dunn is listed there as Principal. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Charles Dunn listed at?
Charles Dunn is listed as Principal at SV Health Investors' Dementia Discovery Fund (DDF). 17 other people in the database share a firm with Charles Dunn.
How do I contact Charles Dunn?
An email address, a phone number and a LinkedIn page are on file for Charles Dunn. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal